drugset / Trial / NCT07174895

Tranexamic Acid and Drain Use in Knee Arthroplasty

NCT07174895 ↗

Completed 192 enrolled Idlib University
RandomizedParallel-groupOpen-labelTreatment

Summary

This prospective randomized clinical study is designed to evaluate the effects of intra-articular tranexamic acid (TNA), with or without suction drainage, on perioperative blood management in patients undergoing total knee arthroplasty (TKA) for degenerative arthritis. A total of 192 patients will be randomly assigned to three groups: Group 1 will receive TNA with suction drainage, Group 2 will receive TNA only, and Group 3 will receive suction drainage only. The primary outcomes will be total blood loss and transfusion requirements. Secondary outcomes will include hidden blood loss, drainage volume, postoperative limb swelling, wound-related complications, and knee range of motion. The study will help clarify whether suction drainage is necessary when intra-articular TNA is used during TKA.

Timeline

Start
2021-08-06
Primary completion
2025-04-01
Completion
2025-04-01

Outcome

Missed primary endpoint

paper did not show the non-inferiority of group L to group D (883 ± 248 vs. 841 ± 257 ml, P = .564). PMID 35109837 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 3 g Other

Indications